"Federal Officials and 12 States Push for Marijuana Rescheduling"

Federal scientists have recommended removing marijuana from the most restrictive category of drugs, citing its potential medical benefits and lower risk compared to other controlled substances. The 250-page scientific review, obtained through a lawsuit, suggests reclassifying marijuana as a Schedule III drug, based on findings that it has therapeutic uses for conditions like anorexia and pain, and does not produce serious outcomes compared to drugs in Schedules I or II. The recommendation is being considered by the Drug Enforcement Administration, with potential implications for federal drug policy and the marijuana industry.